Patents by Inventor Catherine Vayssier

Catherine Vayssier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11752168
    Abstract: A skin care composition is disclosed comprising at least one exopolysaccharide (EPS) originating from a microbial mat, the EPS being in a concentration of about 0.001% w/w to about 1.5% w/w of the composition. Uses and methods of use thereof. In specific embodiments, the EPSs are derived from microorganisms isolated from microbial mats found in French Polynesia. The composition is useful in reducing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration.
    Type: Grant
    Filed: May 12, 2021
    Date of Patent: September 12, 2023
    Assignee: LUCAS MEYER COSMETICS CANADA INC.
    Inventors: Estelle Loing, Sandrine Briatte, Patrice Dionne, Martin Beaulieu, Xavier Moppert, Laurent Richert, Catherine Vayssier
  • Publication number: 20210330691
    Abstract: A skin care composition is disclosed comprising at least one exopolysaccharide (EPS) originating from a microbial mat, the EPS being in a concentration of about 0.001% w/w to about 1.5% w/w of the composition. Uses and methods of use thereof. In specific embodiments, the EPSs are derived from microorganisms isolated from microbial mats found in French Polynesia. The composition is useful in reducing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration.
    Type: Application
    Filed: May 12, 2021
    Publication date: October 28, 2021
    Inventors: Estelle LOING, Sandrine BRIATTE, Patrice DIONNE, Martin BEAULIEU, Xavier MOPPERT, Laurent RICHERT, Catherine VAYSSIER
  • Patent number: 11040058
    Abstract: A skin care composition is disclosed comprising at least one exopolysaccharide (EPS) originating from a microbial mat, the EPS being in a concentration of about 0.001% w/w to about 1.5% w/w of the composition. Uses and methods of use thereof. In specific embodiments, the EPSs are derived from microorganisms isolated from microbial mats found in French Polynesia. The composition is useful in reducing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: June 22, 2021
    Assignee: Lucas Meyer Cosmetics Canada Inc.
    Inventors: Estelle Loing, Sandrine Briatte, Catherine Vayssier, Martin Beaulieu, Patrice Dionne, Laurent Richert, Xavier Moppert
  • Publication number: 20180256627
    Abstract: A skin care composition is disclosed comprising at least one exopolysaccharide (EPS) originating from a microbial mat, the EPS being in a concentration of about 0.001% w/w to about 1.5% w/w of the composition. Uses and methods of use thereof. In specific embodiments, the EPSs are derived from microorganisms isolated from microbial mats found in French Polynesia. The composition is useful in reducing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Inventors: Estelle Loing, Sandrine Briatte, Catherine Vayssier, Martin Beaulieu, Patrice Dionne, Laurent Richert, Xavier Moppert
  • Publication number: 20110150795
    Abstract: Disclosed herein is a skin care composition comprising at least one exopolysaccharide (EPS) originating from a microbial mat, wherein the EPS is in a concentration of about 0.001% w/w to about 1.5 w/w of the composition. Preferably, the EPS is derived from microorganism isolated from microbial mats found in French Polynesia. The composition is useful in reducing and preventing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration.
    Type: Application
    Filed: April 15, 2009
    Publication date: June 23, 2011
    Applicant: Innovactiv Inc.
    Inventors: Estelle Loing, Sandrine Briatte, Catherine Vayssier, Martin Beaulieu, Patrice Dionne, Laurent Richert, Xavier Moppert
  • Publication number: 20040171802
    Abstract: The present invention relates to polypeptides of Haemophilus influenzae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: April 2, 2003
    Publication date: September 2, 2004
    Inventors: Josee Hamel, France Couture, Bernard R. Brodeur, Denis Martin, Catherine Quellet, Mireille Tremblay, Annie Charbonneau, Catherine Vayssier